SEWON E&C

Sewon E&C is a South Korean corporation that operates at the intersection of industrial engineering and regenerative medicine. Formerly known as Sewon Cellontech, the company is a pioneer in the Korean biotech industry, having developed Chondron, the nation's first autologous cell therapy for cartilage repair. Its healthcare division utilizes the proprietary Regenerative Medical System (RMS) platform to produce bio-collagen products and cell-based therapies for orthopedics and dermatology. Recently, Sewon E&C has expanded its portfolio into advanced medical devices, specifically focusing on wearable OLED patches designed for photodynamic therapy and accelerated skin regeneration. The company maintains a robust commercial presence with multiple approved products in the Asian and European markets.